Scarica l'app Stockscreener
1.17
2.50%
-0.03
Dopo l'orario di chiusura:
1.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.20
Aprire:
$1.21
Volume 24 ore:
52.60M
Relative Volume:
1.59
Capitalizzazione di mercato:
$1.09B
Reddito:
$829.22M
Utile/perdita netta:
$-248.96M
Rapporto P/E:
-3.90
EPS:
-0.3
Flusso di cassa netto:
$-92.10M
1 W Prestazione:
-0.85%
1M Prestazione:
-7.14%
6M Prestazione:
-34.64%
1 anno Prestazione:
-41.50%
Intervallo 1D:
$1.16
$1.21
Intervallo di 1 settimana:
$1.15
$1.23
Portata 52W:
$1.14
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Confronta TLRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.17 | 1.09B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Stock Price Down 2.1%Here's Why - MarketBeat
(01/21/25) Top Picks 2025: Tilray Brands (TLRY) - Moneyshow.com
Craft Beer Market Size to is Expected to Reach USD 242.79 billion by 2033, at a CAGR of 9.5% | Straits Research - GlobeNewswire Inc.
Cannabis Stocks To Follow NowJanuary 20th - MarketBeat
Tilray Q2 Earnings: What’s the Plan Here? - The Deep Dive
Tilray (NASDAQ:TLRY) Trading 0.8% HigherStill a Buy? - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Up 1.3%Should You Buy? - MarketBeat
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Trading Up 2.1%Still a Buy? - MarketBeat
Tilray Brands (TSE:TLRY) Sets New 52-Week LowHere's Why - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 1.7%Should You Sell? - MarketBeat
Tilray Brands (TLRY) Stock Declines Following Q4 Earnings - GuruFocus.com
Roth Capital Has Bearish Estimate for Tilray FY2025 Earnings - MarketBeat
Tilray Brands (TSE:TLRY) Hits New 12-Month LowHere's Why - MarketBeat
Tilray has price target chopped at Haywood - Cantech Letter
Why Tilray Stock Plummeted by 42% in 2024 - MSN
Breckenridge Brewery Launches New Seasonal Brew: Spring Forward Grapefruit IPA - StreetInsider.com
Tilray Brands Inc. stock remains steady Tuesday, still outperforms market - MarketWatch
Peering Into Tilray Brands's Recent Short Interest - Benzinga
Jefferies maintains Buy on Tilray stock with $2.50 target - Investing.com
Tilray: Back To Square One (Rating Downgrade) (NASDAQ:TLRY) - Seeking Alpha
Breckenridge Brewery Unveils Spring Forward Grapefruit IPA, A Zesty New Seasonal Release - StockTitan
U.S. legalization could add $250 million to Tilray’s books - Green Market Report
Tilray Brands Inc. stock falls Monday, underperforms market - MarketWatch
Tilray Brands cutting hundreds of SKUs from drinks portfolio - MSN
Tilray (NASDAQ:TLRY) Price Target Raised to $3.00 - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 4.1% Following Weak Earnings - MarketBeat
Tilray Brands, Inc. (TLRY) Outperforms Broader Market: What You Need to Know - MSN
Tilray Brands, Inc. (NASDAQ:TLRY) Q2 2025 Earnings Call Transcript - Insider Monkey
Tilray Brands Second Quarter 2025 Earnings: Misses Expectations - Simply Wall St
Is Tilray (TLRY) a Risky Investment or an Untapped Opportunity? - TipRanks
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates - MSN
Tilray’s stock slumps as cannabis and beer maker plans to cut its drinks lineup - MSN
Tilray Reports Growth in Q2 2025 Amid Losses - MSN
Tilray Brands Inc (TLRY) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions - Yahoo Finance
Tilray Brands Inc (TLRY) Q2 2025 Earnings Call Highlights: Reven - GuruFocus.com
Nvidia-Aurora partnership, Tilray Brands earnings: Market Domination - Yahoo Finance
Tilray Brands Inc. stock falls Friday, underperforms market - MarketWatch
Tilray posts Q2 revenue miss, CEO talks beer market growth - Yahoo Finance
Tilray Brands Inc. (TLRY) reports earnings - Quartz
Market movers: Walgreens, Delta, Constellation Brands, Tilray... - Proactive Investors UK
Why Is Intellia Therapeutics Stock Trading Lower On Friday? - AOL
Why Tilray Brands Stock Crashed 12% on Friday - MSN
‘I like what we’re doing,’ Tilray CEO says despite Q2 earnings miss - BNN Bloomberg
Tilray Brands (TLRY) Q2 2025 Earnings Call Transcript - Yahoo! Voices
Why Tilray (TLRY) Shares Are Plunging Today - Yahoo Finance
Why Tilray (TLRY) Shares Are Plunging Today By Stock Story - Investing.com Canada
Tilray Brands Inc (NASDAQ:TLRY) Misses Revenue Expectations - FXDailyReport.com
Tilray reports $65.7 million from cannabis sales in Q2 2025 - StratCann
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):